In one paragraphArticle in Pathogens (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Haneul JungDivision of Vectors and Parasitic Diseases, Korea Disease Control and Prevention Agency, 187 Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu, Cheongju 28159, Chungcheongbuk-do, Republic of Korea.ORCID 0009-0009-6443-6456 Hyun-Il ShinDivision of Zoonotic and Vector Borne Disease Control, Korea Disease Control and Prevention Agency, 187 Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu, Cheongju 28159, Chungcheongbuk-do, Republic of Korea.ORCID 0000-0001-8146-7208 Bora KuDivision of Vectors and Parasitic Diseases, Korea Disease Control and Prevention Agency, 187 Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu, Cheongju 28159, Chungcheongbuk-do, Republic of Korea.ORCID 0009-0007-8821-0422 Esther ParkDivision of Vectors and Parasitic Diseases, Korea Disease Control and Prevention Agency, 187 Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu, Cheongju 28159, Chungcheongbuk-do, Republic of Korea.
Myoung-Ro LeeDivision of Vectors and Parasitic Diseases, Korea Disease Control and Prevention Agency, 187 Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu, Cheongju 28159, Chungcheongbuk-do, Republic of Korea.ORCID 0000-0003-3369-0063 Jung-Won JuDivision of Vectors and Parasitic Diseases, Korea Disease Control and Prevention Agency, 187 Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu, Cheongju 28159, Chungcheongbuk-do, Republic of Korea.ORCID 0000-0001-5248-6995 Hee-Il LeeDivision of Vectors and Parasitic Diseases, Korea Disease Control and Prevention Agency, 187 Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu, Cheongju 28159, Chungcheongbuk-do, Republic of Korea.ORCID 0000-0002-1636-0639 Funding
Korea Disease Control and Prevention Agency 6300-6332-305
6 · The paper itselfAbstract
In the Republic of Korea (ROK), chloroquine is the first-line treatment for
Indexed as
AntimalarialsDrug ResistanceMalaria, FalciparumMalaria, VivaxPlasmodium falciparumPlasmodium vivaxHumansMutationProtozoan ProteinsRepublic of KoreaAntimalarialsProtozoan Proteinsdrug resistancemalariaPfcyt-bPfK13Pfmdr-1Pvmdr-1Republic of Korea
Identifiers
PMID42198634
PMCPMC13209635
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390